Ricerc@Sapienza

The management of Human Immunodeficiency Virus type 1 (HIV-1) infection requires life-long treatment that is associated with chronic toxicity and possible selection of drug-resistant strains. A new opportunity for drug intervention is offered by antivirals that act as allosteric inhibitors targeting two viral functions (dual inhibitors). In this work, we investigated the effects of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) derivatives on both HIV-1 Integrase (IN) and Reverse Transcriptase associated Ribonuclease H (RNase H) activities.

In this paper, a new model describing the human immunodeficiency virus (HIV)-acquired immuno deficiency syndrome (AIDS) epidemic spread is proposed. The improvement with respect to the known models has been driven by recent results obtained from historical data collection and the suggestions given by the World Health Organization: the characteristics of the virus diffusion, mainly by body fluids, imply the trivial fact that wise behaviors of healthy subjects and fast timely recognition of a new positive diagnosis should reduce the spread quite fast.